HPV vaccination of immunocompromised hosts

Authors :: Anna-Barbara Moscicki
S. de Sanjose
Joel M. Palefsky
R. Sankaranarayanan
Margaret Stanley
Andreas M. Kaufmann
Julia M.L. Brotherton
Suzanne M. Garland
Neerja Bhatla
Source :: Papillomavirus Research, Papillomavirus Research, Vol 4, Iss, Pp 35-38 (2017), Recercat. Dipósit de la Recerca de Catalunya, instname, Dipòsit Digital de la UB, Universidad de Barcelona
Publication Year :: 2017
Publisher :: Elsevier, 2017.
Abstract: It is well-established that immunocompromised people are at increased risk of HPV-related disease compared with those who are immunocompetent. Prophylactic HPV sub-unit vaccines are safe and immunogenic in immunocompromised people and it is strongly recommended that vaccination occur according to national guidelines. When delivered to immunocompromised populations, HPV vaccines should be given as a 3-dose regimen. Keywords: Human papillomavirus (HPV), Vaccination, Immunocompromised hosts, HPV related cancers, HPV Guidelines

Tools